Vanguard Group’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $2.16M | Buy |
|
|||||
|
2024
Q2 | $3.16M | Sell |
|
|||||
|
2024
Q1 | $3.36M | Buy |
|
|||||
|
2023
Q4 | $3.34M | Sell |
|
|||||
|
2023
Q3 | $10.1M | Buy |
|
|||||
|
2023
Q2 | $12.1M | Sell |
|
|||||
|
2023
Q1 | $21.5M | Sell |
|
|||||
|
2022
Q4 | $22.3M | Sell |
|
|||||
|
2022
Q3 | $20.5M | Buy |
|
|||||
|
2022
Q2 | $34.3M | Sell |
|
|||||
|
2022
Q1 | $38.6M | Buy |
|
|||||
|
2021
Q4 | $38.7M | Sell |
|
|||||
|
2021
Q3 | $42.6M | Buy |
|
|||||
|
2021
Q2 | $32.2M | Sell |
|
|||||
|
2021
Q1 | $32.3M | Buy |
|
|||||
|
2020
Q4 | $35.6M | Buy |
|
|||||
|
2020
Q3 | $31.4M | Buy |
|
|||||
|
2020
Q2 | $35.2M | Sell |
|
|||||
|
2020
Q1 | $34M | Sell |
|
|||||
|
2019
Q4 | $45.7M | Buy |
|
|||||
|
2019
Q3 | $43M | Buy |
|
|||||
|
2019
Q2 | $42M | Sell |
|
|||||
|
2019
Q1 | $38.1M | Buy |
|
|||||
|
2018
Q4 | $29.3M | Buy |
|
|||||
|
2018
Q3 | $46.8M | Buy |
|
|||||
|
2018
Q2 | $46.6M | Buy |
|
|||||
|
2018
Q1 | $30.5M | Buy |
|
|||||
|
2017
Q4 | $30.4M | Buy |
|
|||||
|
2017
Q3 | $33.8M | Buy |
|
|||||
|
2017
Q2 | $44.3M | Buy |
|
|||||
|
2017
Q1 | $38M | Buy |
|
|||||
|
2016
Q4 | $34M | Buy |
|
|||||
|
2016
Q3 | $29.4M | Buy |
|
|||||
|
2016
Q2 | $14.1M | Buy |
|
|||||
|
2016
Q1 | $14.2M | Sell |
|
|||||
|
2015
Q4 | $31.8M | Sell |
|
|||||
|
2015
Q3 | $42.5M | Buy |
|
|||||
|
2015
Q2 | $25.5M | Buy |
|
|||||
|
2015
Q1 | $8.48M | Buy |
|
|||||
|
2014
Q4 | $542K | Buy |
|
|||||
|
2014
Q3 | $420K | Buy |
|
|||||
|
2014
Q2 | $176K | Buy |
|